|
|
| | Coelenterazine cp Basic information |
| Product Name: | Coelenterazine cp | | Synonyms: | CTZ cp;COELENTERAZINE CP;CLZN-CP;2-[(4-hydroxyphenyl)methyl]-6-(4-hydroxyphenyl)-8-(cyclopenylmethyl)-imdazo[1,2-a]pyrazin-3-(7h)-one;8-(cyclopentylmethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-7H-imidazo[1,2-a]pyrazin-3-one;Imidazo[1,2-a]pyrazin-3(7H)-one, 8-(cyclopentylmethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-;Dorzolamide Impurity 16;Coelenterin CP | | CAS: | 123437-25-2 | | MF: | C25H25N3O3 | | MW: | 415.48 | | EINECS: | | | Product Categories: | Heterocycle;Imidazo[1,2-a]pyrazin-3(7H)-one | | Mol File: | 123437-25-2.mol |  |
| | Coelenterazine cp Chemical Properties |
| Melting point | >200℃ | | Boiling point | 615.1±65.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | solubility | Soluble in ethanol, methanol | | pka | 9.91±0.15(Predicted) | | form | solid | | color | Yellow | | λmax | 430nm | | Biological Applications | Calcium indicator; measuring luciferase activity; as a substrate for luciferase; screening HIV-1 protease inhibitors |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | Coelenterazine cp Usage And Synthesis |
| Biochem/physiol Actions | 15 times higher luminescence and faster response time than native coelenterazine (Prod. No. C2230). |
| | Coelenterazine cp Preparation Products And Raw materials |
|